BDO Wealth Advisors’s Sage Therapeutics SAGE Stock Holding History

BDO Wealth Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-180	Closed	-$10K	–	1114
2021 Q2	$10K	Hold	180	–	–	﹤0.01%	751
2021 Q1	$13K	Hold	180	–	–	﹤0.01%	696
2020 Q4	$16K	Buy	180 +135	+300%	+$9.95K	﹤0.01%	494
2020 Q3	$3K	Hold	45	–	–	﹤0.01%	648
2020 Q2	$2K	Hold	45	–	–	﹤0.01%	636
2020 Q1	$1K	Buy	+45	New	+$2.61K	﹤0.01%	719
2018 Q3	–	Sell	-65	Closed	-$10K	–	654
2018 Q2	$10K	Buy	+65	New	+$10.2K	﹤0.01%	460

Other funds holding SAGE

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BDO Wealth Advisors's SAGE Position: Q3 2021 in Review

BDO Wealth Advisors sold out of Sage Therapeutics (SAGE) in Q3 2021, closing a stake of 180 shares — an estimated $10K sold.

BDO Wealth Advisors first reported a position in SAGE in Q2 2018 and held it in 7 quarters. The position peaked at $16K in Q4 2020. 226 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

BDO Wealth Advisors reported no remaining Sage Therapeutics position as of Q3 2021 after selling out during the quarter.
BDO Wealth Advisors sold 180 Sage Therapeutics shares in Q3 2021, an estimated $10K.
BDO Wealth Advisors first reported a position in Sage Therapeutics in Q2 2018 and held it in 7 quarters.
BDO Wealth Advisors's Sage Therapeutics position peaked at $16K in Q4 2020.
226 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on BDO Wealth Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.